Phase 2B Dose Ranging Study of Locteron Plus Ribavirin to Treat HCV
Public ClinicalTrials.gov record NCT00863239. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase 2B, Partially Blinded, Randomized Study in Treatment Naive HCV G1 to Compare the Efficacy, Safety, and Tolerability of Three Doses of Locteron Plus Ribavirin Given Bi-weekly in Comparison With PEG-Intron Plus Ribavirin Given Weekly
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of the study was to assess in subjects with chronic hepatitis C (treatment-naïve, genotype 1) receiving weight-based doses of ribavirin the virologic response to 3 dose levels of Locteron™, dosed every 2 weeks, in comparison with PEG-Intron™ dosed weekly.
Study identification
- NCT ID
- NCT00863239
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 116 participants
Conditions and interventions
Conditions
Interventions
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 69 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 2009 (Type not available)
- Primary completion
- Nov 2010 (Actual)
- Completion
- Nov 2011 (Actual)
- Last update posted
- Feb 2, 2012
2009 – 2011
United States locations
- U.S. sites
- 13
- U.S. states
- 9
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| eStudy site | Chula Vista | California | 91911 | — |
| eStudy Site | Oceanside | California | 92056 | — |
| Medical Associates Research Group | San Diego | California | 92123 | — |
| University of Louisville Health Care Outpatient Center | Louisville | Kentucky | 40202 | — |
| Maryland Digestive Disease Research, LLC | Laurel | Maryland | 20707 | — |
| St. Louis University | St Louis | Missouri | 63104 | — |
| AGA Clinical Research Associates, LLC. | Egg Harbor | New Jersey | 08234 | — |
| Montefiore Medical Center | The Bronx | New York | 10467 | — |
| Consultants for Clinical Research | Cincinnati | Ohio | 45219 | — |
| The Liver Institute at Methodist Dallas | Dallas | Texas | 75203 | — |
| Alamo Medical Center | San Antonio | Texas | 78215 | — |
| Inova Fairfax Hospital | Falls Church | Virginia | 22042 | — |
| McGuire DVAMC | Richmond | Virginia | 23249 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 11 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00863239, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 2, 2012 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00863239 live on ClinicalTrials.gov.